These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. IFN-γ production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells. Ishikawa H; Tanaka K; Kutsukake E; Fukui T; Sasaki H; Hata A; Noda S; Matsumoto T Virology; 2010 Nov; 407(2):325-32. PubMed ID: 20855097 [TBL] [Abstract][Full Text] [Related]
23. Abnormalities of peripheral blood T lymphocytes and natural killer cells in alcoholic hepatitis persist after a 3-month withdrawal period. Laso FJ; Madruga JI; López A; Ciudad J; Alvarez-Mon M; San Miguel J; Orfao A Alcohol Clin Exp Res; 1997 Jun; 21(4):672-6. PubMed ID: 9194923 [TBL] [Abstract][Full Text] [Related]
24. Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96. Pilla L; Squarcina P; Coppa J; Mazzaferro V; Huber V; Pende D; Maccalli C; Sovena G; Mariani L; Castelli C; Parmiani G; Rivoltini L Cancer Res; 2005 May; 65(9):3942-9. PubMed ID: 15867395 [TBL] [Abstract][Full Text] [Related]
25. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells. Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624 [TBL] [Abstract][Full Text] [Related]
26. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose. Zollner TM; Zhu HG; Anderer FA Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560 [TBL] [Abstract][Full Text] [Related]
27. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491 [TBL] [Abstract][Full Text] [Related]
28. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies. Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557 [TBL] [Abstract][Full Text] [Related]
29. Immunosynapse formation coincides with rapid activation of NK cells by syngeneic T cells and correlates with clustering of MHC class I. Rabinovich BA; Li J; Hurren R; Miller RG Int Immunol; 2005 Jun; 17(6):671-6. PubMed ID: 15899925 [TBL] [Abstract][Full Text] [Related]
30. Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice. Gao K; Li X; Zhang L; Bai L; Dong W; Gao K; Shi G; Xia X; Wu L; Zhang L Cancer Lett; 2013 Jul; 335(2):463-71. PubMed ID: 23499895 [TBL] [Abstract][Full Text] [Related]
31. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564 [TBL] [Abstract][Full Text] [Related]
32. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease. Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336 [TBL] [Abstract][Full Text] [Related]
33. In vivo antitumor activity of anti-CD3-induced activated killer cells. Yun YS; Hargrove ME; Ting CC Cancer Res; 1989 Sep; 49(17):4770-4. PubMed ID: 2527087 [TBL] [Abstract][Full Text] [Related]
34. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292 [TBL] [Abstract][Full Text] [Related]
35. Strain- and age-dependent natural and activated in vitro cytotoxicity in athymic nude mice. Radzikowski C; Rygaard J; Budzynski W; Stenvang JP; Schou M; Vangsted A; Zeuthen J APMIS; 1994 Jul; 102(7):481-8. PubMed ID: 7917216 [TBL] [Abstract][Full Text] [Related]
36. Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells. Kaur K; Ko MW; Ohanian N; Cook J; Jewett A Sci Rep; 2020 Nov; 10(1):20363. PubMed ID: 33230147 [TBL] [Abstract][Full Text] [Related]
37. The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis. Jensen M; Ernestus K; Kemshead J; Klehr M; Von Bergwelt-Baildon MS; Schinköthe T; Schultze JL; Berthold F Clin Exp Immunol; 2003 Nov; 134(2):253-63. PubMed ID: 14616785 [TBL] [Abstract][Full Text] [Related]
38. The Hedgehog inhibitor cyclopamine impairs the benefits of immunotherapy with activated T and NK lymphocytes derived from patients with advanced cancer. Onishi H; Morisaki T; Kiyota A; Koya N; Tanaka H; Umebayashi M; Katano M Cancer Immunol Immunother; 2013 Jun; 62(6):1029-39. PubMed ID: 23591983 [TBL] [Abstract][Full Text] [Related]
39. Mathematical model of tumor-immune surveillance. Mahasa KJ; Ouifki R; Eladdadi A; Pillis L J Theor Biol; 2016 Sep; 404():312-330. PubMed ID: 27317864 [TBL] [Abstract][Full Text] [Related]
40. Time-lapse microcinematographic analysis of the natural cytotoxicity of murine lymphocytes: morphology of living natural killer (NK) cells. Ebina T; Yamaguchi T; Saito M; Ishida N Microbiol Immunol; 1982; 26(11):1095-9. PubMed ID: 7167064 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]